Boothbay Fund Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $380K | Sell |
|
|||||
|
2025
Q2 | $2.46M | Sell |
|
|||||
|
2025
Q1 | $9.93M | Sell |
|
|||||
|
2024
Q4 | $10.4M | Buy |
|
|||||
|
2024
Q3 | $9.07M | Sell |
|
|||||
|
2024
Q2 | $13.2M | Buy |
|
|||||
|
2024
Q1 | $2.35M | Buy |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $104K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $557K | Buy |
|
|||||
|
2018
Q2 | $80K | Buy |
|